Sigma Metric Analysis
Glucose meters are coming under renewed scrutiny - off-label use with critcally ill patients, infection issues, and new draft guidelines for tighter requirements for FDA clearance. We take a look at a current glucose meter to see if current performance is meeting today's goals - and possibly tomorrow's...
An analysis of 5 different point-of-care (POC) analyzers for C-Reactive Protein (CRP). Many years ago, assays were considered to be too imprecise to support their clinical use. Are the latest instruments any better?
A 2013 study evaluated the analytical performance of a POC blood analysis system. Are we seeing improvements in POC performance? Are there additional sources of error that need to be tracked when we evaluate POC devices?
A recent online publication combined a laboratory and field evaluation of two POC testing devices for lipids and glucose. Are we seeing good POC performance in real-world settings?
As part of our continuing series of evaluations, we take a look at three point-of-care (POC) blood glucose analyzers. We use a paper that evaluates them for use in a specific critical setting: a neonatal intensive care unit.